Rankings
▼
Calendar
ORGO Q4 2019 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
Q4 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$75M
+17.4% YoY
Gross Profit
$54M
72.7% margin
Operating Income
-$2M
-2.3% margin
Net Income
-$4M
-5.9% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
+16.2%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$10M
Stock-Based Comp.
$236,000
Balance Sheet
Total Assets
$221M
Total Liabilities
$165M
Stockholders' Equity
$56M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$75M
$64M
+17.4%
Gross Profit
$54M
$46M
+17.7%
Operating Income
-$2M
-$4M
+60.8%
Net Income
-$4M
-$9M
+52.5%
Revenue Segments
Advanced Wound care
$63M
85%
Surgical and Sports Medicine
$11M
15%
← FY 2019
All Quarters
Q1 2020 →